1990―2019年中国甲状腺癌死亡趋势分析

姚承志; 徐杰茹; 张敏; 段朝晖; 赵湘铃; 熊文婧; 让蔚清

doi:10.16462/j.cnki.zhjbkz.2023.06.019

1990―2019年中国甲状腺癌死亡趋势分析

doi: 10.16462/j.cnki.zhjbkz.2023.06.019

1.
南华大学公共卫生学院社会医学与卫生事业管理教研室，衡阳 421001
2.
南华大学附属第一医院中医科，衡阳 421001

基金项目:

国家自然科学基金 81673107

详细信息

通讯作者:
让蔚清，E-mail: nhurwq@126.com

中图分类号: R736.1; R181
计量
- 文章访问数: 262
- HTML全文浏览量: 140
- PDF下载量: 37
- 被引次数: 0
出版历程
- 收稿日期: 2022-04-03
- 修回日期: 2022-06-10
- 网络出版日期: 2023-07-10
- 刊出日期: 2023-06-10

Analysis of trends in thyroid cancer deaths in China from 1990 to 2019

1.
Department of Social Medicine and Health Administration, School of Public Health, University of South China, Hengyang 421001, China
2.
Department of traditional Chinese medicine, The First Affiliated Hospital of University of South China, Hengyang 421001, China

Funds:

National Natural Science Foundation of China 81673107

More Information

Corresponding author: RANG Weiqing, E-mail: nhurwq@126.com

摘要

摘要: 目的分析1990―2019年我国不同性别甲状腺癌死亡趋势，探讨性别趋势差异原因及高危人群。方法收集并整理全球健康数据交换库中1990―2019年我国5~＜95岁不同性别甲状腺癌的死亡数据。运用年龄-时期-队列(age-period-cohort, APC)模型分析年龄、时期、出生队列对甲状腺癌死亡率变化的影响。结果 1990―2013年男性甲状腺癌标化死亡率持续上升，在2013年达到最大值后逐渐下降。女性甲状腺癌年龄标化死亡率呈持续下降趋势。APC模型结果显示：男性与女性的净漂移值分别为1.38%、-2.94%。我国不同性别甲状腺癌的死亡风险均随着年龄的增长而增大，男性“J”字形上升趋势更为明显；男性甲状腺癌的死亡风险随着时期和出生队列推移而增大，女性则相反。结论男性年龄标准化死亡率呈先上升后逐渐下降趋势，女性年龄标准化死亡率呈持续下降的趋势。越早出生的高龄女性甲状腺癌死亡风险越高，越晚出生的高龄男性死亡风险越高。
- 甲状腺癌 /
- 死亡率 /
- 年龄-时期-队列模型
Abstract: Objective This study aims to analyze the trends in thyroid cancer mortality among males and females in China from 1990 to 2019, and to explore the underlying causes of the gender-based trend disparities and identify high-risk groups. Methods Thyroid cancer mortality data of males and females aged 5- < 95 years in China from 1990 to 2019 were collected and collated from the Global Health Data Exchange. Age-period-cohort (APC) model was used to analyze the influence of age, period and cohort on the mortality of thyroid cancer. Results The standardized mortality rate of male thyroid cancer continued to rise from 1990 until it peaked in 2013, after which it started to decline gradually. Meanwhile, the age-standardized mortality rate of female thyroid cancer consistently decreased. APC model showed that the net drift of males and females was 1.38% and -2.94%, respectively. Both genders demonstrated an increase in thyroid cancer death risk with age, with the ascending trend of the "J" shape being more pronounced in men. In males, the risk of thyroid death increased with time and cohort, while that of females decreased with time and cohort. Conclusions The age-standardized mortality rate of thyroid cancer among men first increased and then gradually declined, whereas it continuously decreased among women. Older women, particularly those born earlier, demonstrated a higher risk of dying from thyroid cancer. Meanwhile, older men, especially those born more recently, were found to have an elevated risk of death.
- Thyriod cancer /
- Mortality /
- Age-period-cohort model

HTML全文

图 1 1990―2019年全国男性和女性甲状腺癌死亡趋势

Figure 1. Trends in thyroid cancer deaths among men and women in China from 1990 to 2019

下载: 全尺寸图片幻灯片

图 2 1990―2019年全国男性和女性甲状腺癌死亡局部偏移值和净偏移值

Figure 2. The local drift and net drift of the mortality of thyriod cancer in Chinese men and women from 1990 to 2019

下载: 全尺寸图片幻灯片

图 3 全国男性和女性甲状腺癌死亡率的纵向年龄曲线

Figure 3. Longitudinal age curve of thyriod cancer mortality in Chinese men and women

下载: 全尺寸图片幻灯片

图 4 全国男性和女性甲状腺癌死亡率的时期RR值

Figure 4. Period RRs of thyriod cancer mortality in Chinese men and women

下载: 全尺寸图片幻灯片

图 5 全国男性和女性甲状腺癌死亡率的出生队列RR值

Figure 5. Cohort RRs of thyriod cancer mortality in Chinese men and women

下载: 全尺寸图片幻灯片

表 1 全国男性和女性甲状腺癌死亡APC模型检验

Table 1. Thyroid cancer death in Chinese men and women: a APC model test

零假设	男性		女性
零假设	χ²值	P值	χ²值	P值
净偏移=0	119.78	<0.001	369.27	<0.001
总年龄偏差=0	2 224.13	<0.001	199.82	<0.001
总时期偏差=0	73.41	<0.001	1.66	0.798
总队列偏差=0	130.49	<0.001	143.84	<0.001
时期RR值=1	201.58	<0.001	371.95	<0.001
队列RR值=1	551.54	<0.001	531.70	<0.001
总局部偏移=净偏移	127.73	<0.001	142.74	<0.001
注：1. APC：年龄-时期-队列。

下载: 导出CSV

参考文献(27)

[1]	沈婉莹, 谢靖, 周维, 等. 2005—2015年中国甲状腺癌死亡趋势分析[J]. 实用预防医学, 2021, 28(6): 641-644. DOI: 10.3969/j.issn.1006－3110.2021.06.001. Shen WY, Xie J, Zhou W, et al. Trend of deaths from thyroid cancer in China, 2005-2015 [J]. Pract Prev Med, 2021, 28(6): 641-644. DOI: 10.3969/j.issn.1006-3110.2021.06.001.
[2]	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.
[3]	Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2018, 68(6): 394-424. DOI: 10.3322/caac.21492.
[4]	赫捷, 魏文强. 2019中国肿瘤登记年报[M]. 北京: 人民卫生出版社, 2021: 198-199. He J, Wei WQ. 2019 China cancer registry annual report[M]. Bejing: People′s Medical Publishing House, 2021: 198-199.
[5]	赫捷. 2018中国肿瘤登记年报[M]. 北京: 人民卫生出版社, 2019: 178-179. He J. 2018 China cancer registry annual report[M]. Bejing: People′s Medical Publishing House, 2019: 178-179.
[6]	IHME.The Global Burden of Disease: a critical resource for informed policymaking [EB/OL]. (2014-04-18) [2022-06-03]. http://ghdx.healthdata.org/.
[7]	李慧贤, 胡丽, 郑焱, 等. 基于全球疾病负担(GBD)大数据的中国银屑病流行病学负担分析[J]. 中国皮肤性病学杂志, 2021, 35(4): 386-392. DOI: 10.13735/j.cjdv.1001-7089.202003197. Li HX, Hu L, Zheng Y, et al. Analysis of the epidemiological burden of psoriasis in China based on the big data of global burden of disease study(GBD) [J]. Chin J Dermatovenereol, 2021, 35(4): 386-392. DOI: 10.13735/j.cjdv.1001-7089.202003197.
[8]	屈彦, 王天一, 杨津, 等. GBD数据库的数据提取方法与流程[J]. 中国循证心血管医学杂志, 2019, 11(9): 1043-1046. DOI: 10.3969/j.issn.1674-4055.2019.09.04. Qu Y, Wang TY, Yang J, et al. GBD database application and data extraction methods and processes [J]. Chin J Evid Based Cardiovasc Med, 2019, 11(9): 1043-1046. DOI: 10.3969/j.issn.1674-4055.2019.09.04.
[9]	王鹏举, 余莉, 王一卉, 等. 2004―2017年全国0~10岁人群乙型肝炎发病趋势[J]. 中华疾病控制杂志, 2021, 25(5): 571-576. DOI: 10.16462/j.cnki.zhjbkz.2021.05.014. Wang PJ, Yu L, Wang YH, et al. Incidence trend of hepatitis B among people aged 0-10 years in China from 2004 to 2017 [J]. Chin J Dis Control Prev, 2021, 25(5): 571-576. DOI: 10.16462/j.cnki.zhjbkz.2021.05.014.
[10]	Rosenberg PS. A new age-period-cohort model for cancer surveillance research [J]. Stat Methods Med Res, 2019, 28(10-11): 3363-3391. DOI: 10.1177/0962280218801121.
[11]	中华耳鼻咽喉头颈外科杂志编辑委员会头颈外科学组. 分化型甲状腺癌诊治指南专题讨论[J]. 中华耳鼻咽喉头颈外科杂志, 2011, 46(11): 881-886. DOI: 10.3760/cma.j.issn.1673-0860.2011.11.001. Head and neck surgery group, Editorial Committee of Chinese Journal of Otolaryngology Head and neck surgery. Special discussion on diagnosis and treatment guidelines of differentiated thyroid cancer [J]. Chin J Otorhinolaryngol Head Neck Surg, 2011, 46(11): 881-886. DOI: 10.3760/cma.j.issn.1673-0860.2011.11.001.
[12]	陈磊, 徐杰茹, 王冕, 等. 1990―2019年中国肾癌死亡趋势及其年龄-时期-队列分析[J]. 中华疾病控制杂志, 2021, 25(9): 1026-1033, 1111. DOI: 10.16462/j.cnki.zhjbkz.2021.09.007. Chen L, Xu JR, Wang M, et al. Analysis for mortality trend and age-period-cohort of kidney cancer in China from 1990 to 2019 [J]. Chin J Dis Control Prev, 2021, 25(9): 1026-1033, 1111. DOI: 10.16462/j.cnki.zhjbkz.2021.09.007.
[13]	吴春晓, 顾凯, 庞怡, 等. 2016年上海市甲状腺癌发病和死亡情况与2002—2016年间变化趋势分析[J]. 外科理论与实践, 2022, 27(1): 58-65. DOI: 10.16139/j.1007-9610.2022.01.014. Wu CX, Gu K, Pang Y, et al. Thyroid cancer incidence and mortality in Shanghai China 2016 and trends from 2002 to 2016 [J]. J Surg Concepts Pract, 2022, 27(1): 58-65. DOI: 10.16139/j.1007-9610.2022.01.014.
[14]	Haymart MR. Understanding the relationship between age and thyroid cancer [J]. Oncologist, 2009, 14(3): 216-221. DOI: 10.1634/theoncologist.2008-0194.
[15]	Nilubol N, Zhang LS, Kebebew E. Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin [J]. Thyroid, 2013, 23(6): 695-702. DOI: 10.1089/thy.2012.0269.
[16]	宋炳豹, 姜瑛, 姜福全, 等. 老年男性甲状腺癌临床分析[J]. 现代仪器与医疗, 2013, 19(5): 46-48. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYI201305015.htm Song BB, Jiang Y, Jiang FQ, et al. Clinical analysis of elderly male thyroid cancer [J]. Mod Instrum Med Treat, 2013, 19(5): 46-48. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYI201305015.htm
[17]	晏月平, 黄美璇, 郑伊然. 中国人口年龄结构变迁及趋势研究[J]. 东岳论丛, 2021, 42(1): 148-163. DOI: 10.15981/j.cnki.dongyueluncong.2021.01.015. Yan YP, Huang MX, Zheng YR. Study on the changes and trends of population age structure in China [J]. Dongyue Tribune, 2021, 42(1): 148-163. DOI: 10.15981/j.cnki.dongyueluncong.2021.01.015.
[18]	Kim HJ, Kim NK, Choi JH, et al. Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer [J]. Clin Endocrinol (Oxf), 2013, 78(1): 134-140. DOI: 10.1111/j.1365-2265.2012.04506.x.
[19]	吴长华, 王亮, 陈万军. 肥胖与甲状腺癌[J]. 肿瘤, 2016, 36(7): 829-834. DOI: 10.3781/j.issn.1000-7431.2016.55.189. Wu CH, Wang L, Chen WJ. Relationship between obesity and thyroid carcinoma [J]. Tumor, 2016, 36(7): 829-834. DOI: 10.3781/j.issn.1000-7431.2016.55.189.
[20]	平卫伟, 谭红专, 曹文君, 等. 成年人生活方式与体质指数的相关性研究[J]. 中华疾病控制杂志, 2016, 20(11): 1184-1186. DOI: 10.16462/j.cnki.zhjbkz.2016.11.027. Ping WW, Tan HZ, Cao WJ, et al. Correlation study between lifestyle and BMI in adults [J]. Chin J Dis Control Prev, 2016, 20(11): 1184-1186. DOI: 10.16462/j.cnki.zhjbkz.2016.11.027.
[21]	Sipos JA, Mazzaferri EL. Thyroid cancer epidemiology and prognostic variables [J]. Clin Oncol (R Coll Radiol), 2010, 22(6): 395-404. DOI: 10.1016/j.clon.2010.05.004.
[22]	陆一丹, 时开元, 欧笛, 等. 甲状腺微小癌预后风险评估与治疗决策的研究进展[J]. 中国肿瘤, 2020, 29(12): 962-969. DOI: 10.11735/j.issn.1004-0242.2020.12.A013. Lu YD, Shi KY, Ou D, et al. Progress on prognostic risk assessment and treatment strategy for thyroid microcarcinoma [J]. China Cancer, 2020, 29(12): 962-969. DOI: 10.11735/j.issn.1004-0242.2020.12.A013.
[23]	Li Y, Piao J, Li M. Secular trends in the epidemiologic patterns of thyroid cancer in China over three decades: an updated systematic analysis of global burden of disease study 2019 data [J]. Front Endocrinol (Lausanne), 2021, 12: 707233. DOI: 10.3389/fendo.2021.707233.
[24]	《中国肿瘤临床》编辑部. 4·15全国肿瘤防治宣传周[J]. 中国肿瘤临床, 2014, 41(9): 570. https://xuewen.cnki.net/CCND-ZSRB202304190080.html Clinical Oncology in China. April 15 national Cancer Prevention and Treatment Publicity Week [J]. Chin J Clin Oncol, 2014, 41(9): 570. https://xuewen.cnki.net/CCND-ZSRB202304190080.html
[25]	Shao YH, Tsai K, Kim S, et al. Exposure to tomographic scans and cancer risks [J]. JNCI Cancer Spectr, 2019, 4(1): pkz072. DOI: 10.1093/jncics/pkz072.
[26]	欧阳鑫, 谢婉莹, 秦春宏. 甲状腺癌的流行病学特征及其危险因素[J]. 实用医药杂志, 2015, 32(4): 312-315. DOI: 10.14172/j.cnki.issn1671-4008.2015.04.009. Ouyang X, Xie WY, Qin CH. Epidemic characteristics of thyroid cancer, and its risk factors [J]. Pract J Med Pharm, 2015, 32(4): 312-315. DOI: 10.14172/j.cnki.issn1671-4008.2015.04.009.
[27]	世界卫生组织. "过度诊断"可致甲状腺癌误诊率高[J]. 上海医药, 2016, 37(17): 77. https://www.cnki.com.cn/Article/CJFDTOTAL-SYIY201617023.htm World Health Organization. "Overdiagnosis" can lead to a high misdiagnosis rate of thyroid cancer, according to the World Health Organization [J]. Shanghai Med Pharm J, 2016, 37(17): 77. https://www.cnki.com.cn/Article/CJFDTOTAL-SYIY201617023.htm